MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by DipsetKINGon May 04, 2020 11:05am

139 Views

Post# 30983460

RE:NY Times: FDA Orders Companies to Submit Antibody Test Data

Great post! Clean up time is here. More room for MEDMIRA test to shine and swallow up market share.

GLTA

MrHODL wrote:
F.D.A. Orders Companies to Submit Antibody Test Data

The tests are an effort to detect whether a person had been infected with the coronavirus, but results have been widely varied.

The Food and Drug Administration announced on Monday that companies selling coronavirus antibody tests must submit data within the next 10 days or face removal from the market.

The Food and Drug Administration announced on Monday that companies selling coronavirus antibody tests must submit data within the next 10 days or face removal from the market.Credit...David J. Phillip/Associated Press

By Sheila Kaplan

May 4, 2020, 10:26 a.m. ET

Link to New York Times article: https://www.nytimes.com/2020/05/04/health/fda-antibody-tests-coronavirus.html